ResearcherOspedale Generale Regionale Francesco MiulliNo recent work listed

Riccardo Inchingolo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0253-5936; OpenAlex author ID A5016434181. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. Last author DOI 10.3748/wjg.v29.i2.223 ↗
Current status of non-surgical treatment of locally advanced pancreatic cancer. Last author DOI 10.4251/wjgo.v13.i12.2064 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Riccardo Memeo · 2 shared papers, 2021–2023 · strength 0.33
- Paper Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. DOI 10.3748/wjg.v29.i2.223 ↗
- Paper Current status of non-surgical treatment of locally advanced pancreatic cancer. DOI 10.4251/wjgo.v13.i12.2064 ↗
Stavros Spiliopoulos · 2 shared papers, 2021–2023 · strength 0.33
- Paper Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. DOI 10.3748/wjg.v29.i2.223 ↗
- Paper Current status of non-surgical treatment of locally advanced pancreatic cancer. DOI 10.4251/wjgo.v13.i12.2064 ↗
Dimitrios K. Filippiadis · 1 shared paper, 2023 · strength 0.20
- Paper Irreversible electroporation for the management of pancreatic cancer: Current data and future directions. DOI 10.3748/wjg.v29.i2.223 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.